{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T16:32:47Z","timestamp":1787502767802,"version":"build-2736575974"},"reference-count":55,"publisher":"Oxford University Press (OUP)","issue":"12","license":[{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004257","name":"Western Norway Regional Health Authority","doi-asserted-by":"publisher","award":["F-12559"],"award-info":[{"award-number":["F-12559"]}],"id":[{"id":"10.13039\/501100004257","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Immunoglobulin A nephropathy (IgAN) is a common cause of chronic kidney disease (CKD) and identifying early molecular signatures is crucial for IgAN risk stratification and timely intervention. In this study we used serum proteomics to investigate molecular differences between IgAN patients who progressed and those who remained stable before separation in kidney function became apparent.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Serum samples from 40 adults with biopsy-proven IgAN were analysed and classified as progressors (PRs; n\u00a0=\u00a013) or non-progressors (NPs; n\u00a0=\u00a027) based on the estimated glomerular filtration rate slope over a 5- to 6-year follow-up. Samples underwent protein depletion, SP3 digestion, tandem mass tag labelling and liquid chromatography\u2013tandem mass spectrometry analysis. Differentially expressed proteins were identified using Welch\u2019s t-test. Enrichment analysis (Gene Ontology, Kyoto Encyclopedia of Genes and Genomes) was performed with ShinyGO and Cytoscape. Random forest machine learning was applied for classification modelling.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Fifty-two proteins showed a significant differential abundance between PRs and NPs. Enrichment analysis revealed dysregulation in complement cascade, extracellular matrix signalling and renin\u2013angiotensin system in PRs compared with NPs. Finally, the random forest model on this protein set achieved an accuracy of 85.0% and identified NCAM1, F7, ARG1, CLU and ANXA5 among the most important predictors.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Serum proteomic profiling identified early molecular differences between PR and NP IgAN patients. These findings support the utility of serum proteomics for early risk stratification in IgAN.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ckj\/sfaf344","type":"journal-article","created":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T12:53:31Z","timestamp":1762865611000},"source":"Crossref","is-referenced-by-count":2,"title":["Serum proteome analysis detects early molecular signatures of disease progression in IgA nephropathy"],"prefix":"10.1093","volume":"18","author":[{"given":"Tony Jialiang","family":"Chen","sequence":"first","affiliation":[{"name":"Faculty of Medicine, University of Bergen Department of Clinical Medicine, , Bergen ,","place":["Norway"]},{"name":"Haukeland University Hospital Department of Internal Medicine, , Bergen ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Skandalou","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Bergen Department of Clinical Medicine, , Bergen ,","place":["Norway"]},{"name":"Haukeland University Hospital Department of Internal Medicine, , Bergen ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarina","family":"Fritz-Wallace","sequence":"additional","affiliation":[{"name":"University of Bergen Department of Biomedicine, , Bergen ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7150-9416","authenticated-orcid":false,"given":"Terje","family":"Apeland","sequence":"additional","affiliation":[{"name":"Stavanger University Hospital Department of Medicine, , Stavanger ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Knoop","sequence":"additional","affiliation":[{"name":"Haukeland University Hospital Department of Internal Medicine, , Bergen ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Peter","family":"Marti","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Bergen Department of Clinical Medicine, , Bergen ,","place":["Norway"]},{"name":"Haukeland University Hospital Department of Internal Medicine, , Bergen ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d8ystein","family":"Eikrem","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Bergen Department of Clinical Medicine, , Bergen ,","place":["Norway"]},{"name":"Haukeland University Hospital Department of Internal Medicine, , Bergen ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8842-534X","authenticated-orcid":false,"given":"Jessica","family":"Furriol","sequence":"additional","affiliation":[{"name":"Faculty of Medicine, University of Bergen Department of Clinical Medicine, , Bergen ,","place":["Norway"]},{"name":"Haukeland University Hospital Department of Internal Medicine, , Bergen ,","place":["Norway"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,11,11]]},"reference":[{"key":"2025120403520908100_bib1","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1056\/NEJMra1206793","article-title":"IgA nephropathy","volume":"368","author":"Wyatt","year":"2013","journal-title":"N Engl J Med"},{"key":"2025120403520908100_bib2","doi-asserted-by":"publisher","first-page":"727","DOI":"10.2215\/CJN.0000000000000135","article-title":"Long-term outcomes in IgA nephropathy","volume":"18","author":"Pitcher","year":"2023","journal-title":"Clin J Am Soc Nephrol"},{"key":"2025120403520908100_bib3","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/j.kint.2017.02.003","article-title":"Oxford classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group","volume":"91","author":"Trimarchi","year":"2017","journal-title":"Kidney Int"},{"key":"2025120403520908100_bib4","doi-asserted-by":"publisher","first-page":"354","DOI":"10.2215\/CJN.05750515","article-title":"The native kidney biopsy: update and evidence for best practice","volume":"11","author":"Hogan","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"2025120403520908100_bib5","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/s12882-021-02653-y","article-title":"Utilizing the MEST score for prognostic staging in IgA nephropathy","volume":"23","author":"Haaskjold","year":"2022","journal-title":"BMC Nephrol"},{"key":"2025120403520908100_bib6","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1186\/s12882-018-1128-6","article-title":"Renal outcomes of STOP-IgAN trial patients in relation to baseline histology (MEST-C scores)","volume":"19","author":"Schimpf","year":"2018","journal-title":"BMC Nephrol"},{"key":"2025120403520908100_bib7","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1007\/s11255-021-02974-9","article-title":"The predictive value of Oxford MEST-C classification to immunosuppressive therapy of IgA nephropathy","volume":"54","author":"Rui","year":"2022","journal-title":"Int Urol Nephrol"},{"key":"2025120403520908100_bib8","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1001\/jamainternmed.2019.0600","article-title":"Evaluating a new international risk-prediction tool in IgA nephropathy","volume":"179","author":"Barbour","year":"2019","journal-title":"JAMA Intern Med"},{"key":"2025120403520908100_bib9","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.freeradbiomed.2022.06.224","article-title":"Association of redox and inflammation-related biomarkers with prognosis in IgA nephropathy: a prospective observational study","volume":"188","author":"Apeland","year":"2022","journal-title":"Free Radic Biol Med"},{"key":"2025120403520908100_bib10","doi-asserted-by":"publisher","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"2025120403520908100_bib11","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nmeth.3901","article-title":"The Perseus computational platform for comprehensive analysis of (prote)omics data","volume":"13","author":"Tyanova","year":"2016","journal-title":"Nat Methods"},{"key":"2025120403520908100_bib12","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1093\/bioinformatics\/btz931","article-title":"ShinyGO: a graphical gene-set enrichment tool for animals and plants","volume":"36","author":"Ge","year":"2019","journal-title":"Bioinformatics"},{"key":"2025120403520908100_bib13","doi-asserted-by":"publisher","first-page":"D545","DOI":"10.1093\/nar\/gkaa970","article-title":"KEGG: integrating viruses and cellular organisms","volume":"49","author":"Kanehisa","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"2025120403520908100_bib14","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1101\/gr.1239303","article-title":"Cytoscape: a software environment for integrated models of biomolecular interaction networks","volume":"13","author":"Shannon","year":"2003","journal-title":"Genome Res"},{"key":"2025120403520908100_bib15","doi-asserted-by":"publisher","first-page":"R53","DOI":"10.1186\/gb-2010-11-5-r53","article-title":"A human functional protein interaction network and its application to cancer data analysis","volume":"11","author":"Wu","year":"2010","journal-title":"Genome Biol"},{"key":"2025120403520908100_bib16","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1021\/acs.jproteome.8b00702","article-title":"Cytoscape stringApp: network analysis and visualization of proteomics data","volume":"18","author":"Doncheva","year":"2019","journal-title":"J Proteome Res"},{"key":"2025120403520908100_bib17","doi-asserted-by":"publisher","first-page":"D543","DOI":"10.1093\/nar\/gkab1038","article-title":"The PRIDE database resources in 2022: a hub for mass spectrometry-based proteomics evidences","volume":"50","author":"Perez-Riverol","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"2025120403520908100_bib18","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1023\/A:1010933404324","article-title":"Random forests","volume":"45","author":"Breiman","year":"2001","journal-title":"Machine Learning"},{"key":"2025120403520908100_bib19","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12014-017-9165-x","article-title":"Glomerular abundance of complement proteins characterized by proteomic analysis of laser-captured microdissected glomeruli associates with progressive disease in IgA nephropathy","volume":"14","author":"Paunas","year":"2017","journal-title":"Clin Proteomics"},{"key":"2025120403520908100_bib20","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s12882-022-02736-4","article-title":"Proteomic signature of tubulointerstitial tissue predicts prognosis in IgAN","volume":"23","author":"Paunas","year":"2022","journal-title":"BMC Nephrol"},{"key":"2025120403520908100_bib21","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1016\/j.medici.2016.11.003","article-title":"IgA nephropathy clinicopathologic study following the Oxford classification: progression peculiarities and gender-related differences","volume":"52","author":"Riispere","year":"2016","journal-title":"Medicina (Kaunas)"},{"key":"2025120403520908100_bib22","doi-asserted-by":"publisher","first-page":"814497","DOI":"10.3389\/fmed.2021.814497","article-title":"New aspects of kidney fibrosis\u2013from mechanisms of injury to modulation of disease","volume":"8","author":"Moeller","year":"2022","journal-title":"Front Med (Lausanne)"},{"key":"2025120403520908100_bib23","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1159\/000045290","article-title":"VCAM-1, ICAM-1, and E-selectin in IgA nephropathy and Sch\u00f6nlein-Henoch syndrome: differences between tissue expression and serum concentration","volume":"81","author":"Mrowka","year":"1999","journal-title":"Nephron"},{"key":"2025120403520908100_bib24","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/1471-2369-14-21","article-title":"Increased plasma sVCAM-1 is associated with severity in IgA nephropathy","volume":"14","author":"Zhu","year":"2013","journal-title":"BMC Nephrol"},{"key":"2025120403520908100_bib25","doi-asserted-by":"crossref","first-page":"1446672","DOI":"10.3389\/fimmu.2024.1446672","article-title":"Targeting AXL cellular networks in kidney fibrosis","volume":"15","author":"Gr\u00f8ndal","year":"2024","journal-title":"Front Immunol"},{"key":"2025120403520908100_bib26","doi-asserted-by":"publisher","first-page":"e0232055","DOI":"10.1371\/journal.pone.0232055","article-title":"Novel AXL-specific inhibitor ameliorates kidney dysfunction through the inhibition of epithelial-to-mesenchymal transition of renal tubular cells","volume":"15","author":"Kurata","year":"2020","journal-title":"PLoS One"},{"key":"2025120403520908100_bib27","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1093\/ndt\/15.3.296","article-title":"Connective tissue growth factor: just another factor in renal fibrosis?","volume":"15","author":"Goldschmeding","year":"2000","journal-title":"Nephrol Dial Transplant"},{"key":"2025120403520908100_bib28","doi-asserted-by":"publisher","first-page":"eads7714","DOI":"10.1126\/scitranslmed.ads7714","article-title":"Collagen V regulates renal function after kidney injury and can be pharmacologically targeted to enhance kidney repair in mice","volume":"17","author":"Su","year":"2025","journal-title":"Sci Transl Med"},{"key":"2025120403520908100_bib29","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1016\/j.kint.2017.02.003","article-title":"Oxford classification of IgA nephropathy 2016: an update from the IgA Nephropathy Classification Working Group","volume":"91","author":"Trimarchi","year":"2017","journal-title":"Kidney Int"},{"key":"2025120403520908100_bib30","doi-asserted-by":"publisher","first-page":"32","DOI":"10.3390\/proteomes9030032","article-title":"A novel urinary proteomics classifier for non-invasive evaluation of interstitial fibrosis and tubular atrophy in chronic kidney disease","volume":"9","author":"Catanese","year":"2021","journal-title":"Proteomes"},{"key":"2025120403520908100_bib31","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1093\/ndt\/gfaa307","article-title":"Urine proteomics for prediction of disease progression in patients with IgA nephropathy","volume":"37","author":"Rudnicki","year":"2021","journal-title":"Nephrol Dial Transplant"},{"key":"2025120403520908100_bib32","doi-asserted-by":"publisher","first-page":"2826","DOI":"10.1093\/ndt\/gfad125","article-title":"Dynamics of urine proteomics biomarker and disease progression in patients with IgA nephropathy","volume":"38","author":"Peters","year":"2023","journal-title":"Nephrol Dial Transplant"},{"key":"2025120403520908100_bib33","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1681\/ASN.2022020161","article-title":"More than a marker: arginase-1 in kidney repair","volume":"33","author":"von Vietinghoff","year":"2022","journal-title":"J Am Soc Nephrol"},{"key":"2025120403520908100_bib34","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1111\/imm.13470","article-title":"Siglec-5 is an inhibitory immune checkpoint molecule for human T cells","volume":"166","author":"Vuchkovska","year":"2022","journal-title":"Immunology"},{"key":"2025120403520908100_bib35","doi-asserted-by":"publisher","first-page":"99125","DOI":"10.18632\/oncotarget.21702","article-title":"Elevated serum fibrinogen level is an independent risk factor for IgA nephropathy","volume":"8","author":"Zhang","year":"2017","journal-title":"Oncotarget"},{"key":"2025120403520908100_bib36","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1038\/ki.2011.214","article-title":"Fibrinogen, acting as a mitogen for tubulointerstitial fibroblasts, promotes renal fibrosis","volume":"80","author":"S\u00f6rensen","year":"2011","journal-title":"Kidney Int"},{"key":"2025120403520908100_bib37","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.molimm.2013.06.001","article-title":"Complement factor H related proteins (CFHRs)","volume":"56","author":"Skerka","year":"2013","journal-title":"Mol Immunol"},{"key":"2025120403520908100_bib38","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1681\/ASN.2017010019","article-title":"Deletion variants of CFHR1 and CFHR3 associate with mesangial immune deposits but not with progression of IgA nephropathy","volume":"29","author":"Jullien","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"2025120403520908100_bib39","doi-asserted-by":"publisher","first-page":"110354","DOI":"10.1016\/j.intimp.2023.110354","article-title":"Roles of mesangial C3 and C1q deposition in the clinical manifestations and prognosis of IgAN","volume":"120","author":"Wang","year":"2023","journal-title":"Int Immunopharmacol"},{"key":"2025120403520908100_bib40","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1007\/s00467-019-04445-x","article-title":"Clinical relevance of membrane attack complex deposition in children with IgA nephropathy and Henoch-Sch\u00f6nlein purpura","volume":"35","author":"Dumont","year":"2020","journal-title":"Pediatr Nephrol"},{"key":"2025120403520908100_bib41","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1111\/j.1365-2249.1992.tb06459.x","article-title":"Clusterin in renal tissue: preferential localization with the terminal complement complex and immunoglobulin deposits in glomeruli","volume":"88","author":"French","year":"2008","journal-title":"Clin Exp Immunol"},{"key":"2025120403520908100_bib42","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1046\/j.1523-1755.2001.00474.x","article-title":"Clusterin is up-regulated in glomerular mesangial cells in complement-mediated injury","volume":"59","author":"Yamada","year":"2001","journal-title":"Kidney Int"},{"key":"2025120403520908100_bib43","doi-asserted-by":"publisher","first-page":"922","DOI":"10.1093\/ckj\/sfab294","article-title":"C5a receptor inhibitor avacopan in immunoglobulin A nephropathy\u2014an open-label pilot study","volume":"15","author":"Bruchfeld","year":"2022","journal-title":"Clin Kidney J"},{"key":"2025120403520908100_bib44","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.ekir.2023.01.041","article-title":"Targeting the alternative complement pathway with iptacopan to treat IgA nephropathy: design and rationale of the APPLAUSE-IgAN Study","volume":"8","author":"Rizk","year":"2023","journal-title":"Kidney Int Rep"},{"issue":"4S","key":"2025120403520908100_bib45","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2021.05.021","article-title":"KDIGO 2021 clinical practice guideline for the management of glomerular diseases","volume":"100","author":"Kidney Disease: Improving Global Outcomes Glomerular Diseases Work Group","year":"2021","journal-title":"Kidney Int"},{"key":"2025120403520908100_bib46","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1016\/j.ekir.2021.02.018","article-title":"Supportive management of IgA nephropathy with renin-angiotensin blockade, the AIIMS Primary IgA Nephropathy Cohort (APPROACH) Study","volume":"6","author":"Bagchi","year":"2021","journal-title":"Kidney Int Rep"},{"key":"2025120403520908100_bib47","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.kint.2020.09.016","article-title":"Neural cell adhesion molecule 1 is a novel autoantigen in membranous lupus nephritis","volume":"100","author":"Caza","year":"2021","journal-title":"Kidney Int"},{"key":"2025120403520908100_bib48","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1093\/ndt\/gfm006","article-title":"Neural cell adhesion molecule expression on renal interstitial cells","volume":"22","author":"Markovi\u0107-Lipkovski","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"2025120403520908100_bib49","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1007\/s00467-018-3924-4","article-title":"Urinary clusterin\u2014a novel urinary biomarker associated with pediatric lupus renal histopathologic features and renal survival","volume":"33","author":"Wu","year":"2018","journal-title":"Pediatr Nephrol"},{"key":"2025120403520908100_bib50","doi-asserted-by":"publisher","first-page":"763","DOI":"10.2217\/bmm.11.86","article-title":"Preclinical Perspective of urinary biomarkers for the detection of nephrotoxicity: what we know and what we need to know","volume":"5","author":"Fuchs","year":"2011","journal-title":"Biomark Med"},{"key":"2025120403520908100_bib51","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1097\/TP.0000000000000256","article-title":"Clusterin in kidney transplantation: novel biomarkers versus serum creatinine for early prediction of delayed graft function","volume":"99","author":"Pianta","year":"2015","journal-title":"Transplantation"},{"key":"2025120403520908100_bib52","doi-asserted-by":"publisher","first-page":"807","DOI":"10.3390\/medicina61050807","article-title":"Prognostic value of urinary biomarkers in proteinuria progression in IgA nephropathy patients treated with budesonide","volume":"61","author":"Keskinis","year":"2025","journal-title":"Medicina (Kaunas)"},{"key":"2025120403520908100_bib53","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.1016\/j.ekir.2025.04.035","article-title":"Urinary clusterin is a biomarker of renal epithelial senescence and predicts human kidney disease progression","volume":"10","author":"Baird","year":"2025","journal-title":"Kidney Int Rep"},{"issue":"Suppl 1","key":"2025120403520908100_bib54","doi-asserted-by":"publisher","first-page":"S43","DOI":"10.1016\/j.placenta.2015.01.193","article-title":"Review: annexin-A5 and cell membrane repair","volume":"36","author":"Bouter","year":"2015","journal-title":"Placenta"},{"key":"2025120403520908100_bib55","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/j.kint.2023.12.010","article-title":"Glomerular transcriptomics predicts long term outcome and identifies therapeutic strategies for patients with assumed benign IgA nephropathy","volume":"105","author":"Rivedal","year":"2024","journal-title":"Kidney Int"}],"container-title":["Clinical Kidney Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ckj\/advance-article-pdf\/doi\/10.1093\/ckj\/sfaf344\/65269409\/sfaf344.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/18\/12\/sfaf344\/65269409\/sfaf344.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ckj\/article-pdf\/18\/12\/sfaf344\/65269409\/sfaf344.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T08:52:15Z","timestamp":1764838335000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ckj\/article\/doi\/10.1093\/ckj\/sfaf344\/8320531"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,11]]},"references-count":55,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12,1]]}},"URL":"https:\/\/doi.org\/10.1093\/ckj\/sfaf344","relation":{},"ISSN":["2048-8505","2048-8513"],"issn-type":[{"value":"2048-8505","type":"print"},{"value":"2048-8513","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,12]]},"published":{"date-parts":[[2025,11,11]]},"article-number":"sfaf344"}}